Taiwan FDA registration d4301d3d803b01a18179c635057dc1b9
Parlor Mini Blood Glucose Test System
TW: 派樂迷你血糖測試系統
Taiwan·Risk Class 2·CHIMEI Biotechnology Co., Ltd.; Ruizhi Biochemical Technology Co., Ltd·Registered Nov 28, 2022 – Jun 02, 2027ActiveRegistration details
- Analysis ID
- d4301d3d803b01a18179c635057dc1b9
Company information
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Chimei Biotechnology Co., Ltd
Product details
- Intended Use
- This product can quantitatively detect the blood glucose value in the whole blood of fresh fingertips, forearms and upper arms, and can be used by diabetic patients at home or by professionals in medical care homes. Not suitable for diabetes diagnosis and screening, and not for infants and young children.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- 國產;; 委託製造;; QMS/QSD
Dates and status
- Registration Date
- Nov 28, 2022
- Expiry Date
- Jun 02, 2027
About this record
Access comprehensive regulatory information for Parlor Mini Blood Glucose Test System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number d4301d3d803b01a18179c635057dc1b9 and manufactured by CHIMEI Biotechnology Co., Ltd.; Ruizhi Biochemical Technology Co., Ltd. The authorized representative in Taiwan is Chimei Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices